Physician

Rachel Ann Rosenbaum, DO

According to 2025 Medicare claims, Rachel Rosenbaum, DO (NPI: 1942523709) practices neuropsychiatry in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is MSU HEALTH CARE INC. (NPI: 1053943928; TIN: 832236308) and primary practice location at 48912-1811. Rosenbaum is affiliated with the POM ACO (ACO ID: A1297) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Rosenbaum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 112 traditional Medicare patients, billed 264 HCPCS/CPT codes, and received $19,565 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 553 prescription claims across 96 beneficiaries totaling $314,544 in drug costs, led by Copaxone (Glatiramer Acetate). 2020 DME data shows 11 claims. Open Payments data shows 32 records totaling $640. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,708 to $314,544. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	35	36	$3,006
2019	250	314	$31,142
2020	299	473	$45,261
2021	257	387	$37,510
2022	257	449	$41,374
2023	227	444	$40,222
2024	112	264	$19,565

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	22	$3,708
2019	55	244	$80,557
2020	101	596	$156,740
2021	118	762	$234,743
2022	84	513	$264,705
2023	98	646	$344,089
2024	96	553	$314,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$386
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	12	19	$147
64615	Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face	23	46	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	25	28	$82
64405	Injection of anesthetic agent and/or steroid into upper neck and back of head nerve	17	46	$58
64450	Injection of anesthetic agent and/or steroid into other nerve or branch	17	46	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Copaxone	Glatiramer Acetate	12	336	$69,984
Ubrelvy	Ubrogepant	48	1,387	$62,348
Briviact	Brivaracetam	19	555	$39,994
Emgality Pen	Galcanezumab-Gnlm	20	588	$14,481
Vimpat	Lacosamide	11	330	$11,955

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$640	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rachel Ann Rosenbaum, DO?

Tedicare shows public-source Medicare data for Rachel Ann Rosenbaum, DO (NPI 1942523709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel Ann Rosenbaum, DO have ACO affiliation data?

Rachel Ann Rosenbaum, DO is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Rachel Ann Rosenbaum, DO?

Rachel Ann Rosenbaum, DO is linked to MSU HEALTH CARE INC. (billing NPI 1053943928) in the available physician profile data.

Does Rachel Ann Rosenbaum, DO have Open Payments data?

Rachel Ann Rosenbaum, DO has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.